NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: Investor Presentation, 14 March 2023, page-5

  1. 580 Posts.
    lightbulb Created with Sketch. 4892
    My question on Fragile X and what was 'in place' with Acadia was answered by Jon.

    What I heard was ... that the terms in the US, for Fragile X were the same ... so ... the deal, levels of payment, royalties, milestones, will be the same, if indeed Acadia decide to push forward with that indication. That of course will be entirely up to Acadia, but as we know, the next step would be a registrational trial ... if they choose that path.

    Personally, I think this might be a possibility, and a very profitable one for both Acadia and more importantly for NEU.

    With the other Phase 2 trials moving forward, and using what they have already learned about the whole process, all I see is 'BLUE SKY'.

    Opinion only of course.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.52
Change
0.660(3.32%)
Mkt cap ! $2.622B
Open High Low Value Volume
$20.00 $20.66 $19.94 $6.431M 315.4K

Buyers (Bids)

No. Vol. Price($)
1 1024 $20.52
 

Sellers (Offers)

Price($) Vol. No.
$20.53 285 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.